NCT03561272

The Validation of a Novel Adherence Method for Oral Oncolytics

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: University of Michigan Rogel Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The long-term goal of this research is to apply technologic approaches to improve the use of oral oncolytics. The objective of this study is to assess patient adherence to oral oncolytics and to validate a currently available smart phone application (iRxReminder) partnered with an automated dispensing device, a "Pod", in affecting patient adherence. The rationale for this study is that medication adherence to oncolytics varies and strategies are needed to improve it.

Conditions

• Cancer

Interventions

Type	Name	Description
OTHER	Smart Phone Application	Oral medication adherence phone application.
OTHER	POD	Pill dispensing system that dispenses the medication, controls dispensed dosage, and confirms dispensing to patient through wireless communication back to the control center.

Timeline

• Start date: 2017-06-20
• Primary completion: 2018-10-31
• Completion: 2018-10-31
• First posted: 2018-06-19
• Last updated: 2019-10-04

Locations

1 site across 1 country: United States